Rocket One Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Rocket One Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- Rocket One Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $495.00.
- Rocket One Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $0.00.
- Rocket One Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $1.86K.
- Rocket One Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $2.35K.
- Rocket One Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $359.51K, a 539.13% increase from fiscal 2020.
- Rocket One Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $56.25K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.35K 10-K · filed 2024-03-28 |
| 2023-09-30 | $495.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | |
| 2023-03-31 | $1.86K 10-Q · filed 2024-11-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $359.51K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $359.51K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $768.00 10-Q · filed 2022-08-12 | $359.51K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $358.75K 10-Q · filed 2022-05-12 | $377.50K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $56.25K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2020-06-30 | $18.75K 10-Q · filed 2021-08-11 | |
| 2020-03-31 | $37.50K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |